Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.468 USD | -1.63% | -3.90% | -87.11% |
04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.11% | 5.31M | |
+11.52% | 116B | |
+12.25% | 106B | |
-7.69% | 23.89B | |
-2.59% | 21.58B | |
-10.77% | 18.96B | |
-40.50% | 16.96B | |
-13.78% | 16.33B | |
+7.10% | 14.14B | |
+33.15% | 12.02B |
- Stock Market
- Equities
- KA Stock
- News Kineta, Inc.
- Kineta Closes $6 Million Registered Direct Offering